Early research (Phase 1)Study completedNCT00438802
What this trial is testing
Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma
Who this might be right for
Lymphoma
Mayo Clinic 23